Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-08-13

Clinical Trial Update: Early Administration of Botox® in Neuropathic Pain Due to Thoracoscopy or Thoracotomy [Phase 3]

View source ↗

Summary

Phase 3 trial on early administration of Botox in neuropathic pain after thoracoscopy/thoracotomy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Pain Due to Certain Specified Procedures, Neuropathic Pain | Phase 3 | Status: WITHDRAWN